Janette L Vardy1, Raymond J Chan2, Bogda Koczwara3, Karolina Lisy4, Richard J Cohn5, David Joske6, Haryana M Dhillon7, Michael Jefford8. 1. BMed (Hons), FRACP, PhD, Professor of Cancer Medicine, University of Sydney, NSW; Director, Sydney Survivorship Centre, NSW; Senior Medical Oncologist, Concord Cancer Centre, NSW. 2. RN, PhD, Professor of Cancer Nursing, Faculty of Health, Queensland University of Technology, Qld; Professor of Cancer Nursing, Division of Cancer Services, Princess Alexandra Hospital, Metro South Health, Qld. 3. AM, BM, BS, FRACP, MBioethics, FAICD, Senior Staff Specialist,@Flinders Centre for Innovation in Cancer, Flinders Medical Centre, SA; Senior Staff Specialist, Department@of Medical Oncology, Flinders University, SA. 4. PhD, Senior Research Fellow, Peter MacCallum Cancer Centre, Vic. 5. MB, BCh (Rand), DCH SA, FCP (Paed) SA, FRACP, Senior Staff Specialist, Clinical Oncology, Kids Cancer Centre, Sydney Children@s Hospital, NSW; Conjoint Professor of Paediatrics, School of Women@s and Children@s Health, University of New South Wales, NSW. 6. FRACP, FRCPA, FCHSM, Medical Co‑Director, Medical Specialties Division, and Clinical Haematologist, Department of Haematology, Sir Charles Gairdner Hospital, WA. 7. PhD, Senior Research Fellow, Centre for Medical Psychology and Evidence-based Decision-making, University of Sydney, NSW. 8. MBBS, MPH, MHlthServMt, PhD, GCertUniTeach, GAICD, FRACP, Director, Australian Cancer Survivorship Centre @ A Richard Pratt Legacy, and Senior Medical Oncologist, Peter MacCallum Cancer Centre, Vic; Professor of Medicine, Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic.
Abstract
BACKGROUND: Cancer survivors often experience long‑term negative consequences of their cancer and cancer treatment. With increasing numbers of survivors and duration of survival, a sustainable model of care is required to better meet the needs of cancer survivors. OBJECTIVE: The aim of this article is to outline the Clinical Oncology Society of Australia Model of Survivorship Care, summarising the critical components of cancer survivorship care. DISCUSSION: Recommendations include: a systematic, multidisciplinary care approach that optimises self-management and enhances coordinated and integrated survivor-centred care from diagnosis; stratified care pathways based on survivors' needs, capacity to self-manage and anticipated treatment sequelae; a focus of care on wellness, healthy lifestyle, symptom management and prevention of life-altering and life threatening late effects in addition to cancer surveillance; development of a treatment summary and care plan; and equitable, timely access to services, while minimising unnecessary use of healthcare services.
BACKGROUND:Cancer survivors often experience long‑term negative consequences of their cancer and cancer treatment. With increasing numbers of survivors and duration of survival, a sustainable model of care is required to better meet the needs of cancer survivors. OBJECTIVE: The aim of this article is to outline the Clinical Oncology Society of Australia Model of Survivorship Care, summarising the critical components of cancer survivorship care. DISCUSSION: Recommendations include: a systematic, multidisciplinary care approach that optimises self-management and enhances coordinated and integrated survivor-centred care from diagnosis; stratified care pathways based on survivors' needs, capacity to self-manage and anticipated treatment sequelae; a focus of care on wellness, healthy lifestyle, symptom management and prevention of life-altering and life threatening late effects in addition to cancer surveillance; development of a treatment summary and care plan; and equitable, timely access to services, while minimising unnecessary use of healthcare services.
Authors: Caitlin B Biddell; Lisa P Spees; Deborah K Mayer; Stephanie B Wheeler; Justin G Trogdon; Jason Rotter; Sarah A Birken Journal: Cancer Date: 2020-12-01 Impact factor: 6.860
Authors: Michael Jefford; Doris Howell; Qiuping Li; Karolina Lisy; Jane Maher; Catherine M Alfano; Meg Rynderman; Jon Emery Journal: Lancet Date: 2022-04-16 Impact factor: 202.731
Authors: Jodie Nixon; Raymond Chan; Emma McKinnell; Elizabeth Ward; Elizabeth Pinkham; Laurelie Wishart; Elizabeth Miller; Bena Brown Journal: Asia Pac J Oncol Nurs Date: 2021-05-22